EVERTON DE SILVA
FULL TIME MSc STUDENT
BIO The place of birth is in Sri Lanka. My age is thirty-four. I have ten years of experience in the medical device industry, with a focus on marketing. I have expertise using microwave tumour ablation technology to treat both benign and malignant tumours that were discovered early on. I have also experience in treatment ways for both acute and chronic wounds. In 2017, I finished my undergraduate studies in International Business Management and went on to the University of Swansea to earn an MSc in Advanced Health and Care Management (Value-Based Healthcare). As an alumnus of the Value-Based Healthcare Master’s program, I possess a comprehensive understanding of healthcare systems, focusing on optimizing value for patients. My expertise lies in implementing strategies to enhance patient outcomes, reduce costs, and improve overall healthcare quality. With a commitment to fostering sustainable, patient-centric approaches, I bring a unique blend of knowledge and practical skills to the ever-evolving field of Value-Based healthcare.
RESEARCH IMPACT Research Topic: The Effects of Value-Based Healthcare Principles in Adopting Microwave Tumor Ablation for Cancer Management in Sri Lanka The implementation of microwave tumor ablation in cancer management involves using microwave energy to heat and destroy cancer cells. This minimally invasive procedure is often used for treating certain types of tumors. From a Value-Based healthcare (VBHC) perspective, microwave tumor ablation can impact healthcare in several ways: 1. Improved Outcomes: By providing an alternative to traditional surgery or radiation therapy, microwave ablation may contribute to improved patient outcomes. This aligns with VBHC’s focus on delivering high-quality care and positive patient experiences. 2. Reduced Costs: Minimally invasive procedures generally lead to shorter hospital stays and quicker recovery times. This can result in cost savings, aligning with VBHC’s goal of optimizing healthcare value by balancing outcomes with costs. 3. Enhanced Patient Experience: Microwave ablation may offer patients a less invasive and more comfortable treatment option compared to traditional therapies. This can positively influence patient satisfaction and aligns with the patient-centered care aspect of VBHC. 4. Measurable Outcomes: VBHC emphasizes the measurement of outcomes that matter to patients. The effectiveness of microwave tumor ablation can be assessed through measures such as tumor response rates, recurrence rates, and long-term survival, providing valuable data for evaluating the value of this intervention. 5. Resource Allocation: VBHC encourages the allocation of resources based on interventions’ effectiveness and impact on patient outcomes. If microwave tumor ablation proves to be a cost-effective and beneficial treatment, healthcare systems may allocate resources accordingly. In summary, the implementation of microwave tumor ablation in cancer management aligns with the principles of Value-Based healthcare by aiming to improve patient outcomes, reduce costs, enhance the patient experience, and provide a basis for informed resource allocation.
Made with FlippingBook HTML5